Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (14076)	11/13/2004 9:36:31 AM
From: tom pope	Respond to of 52153

Ian, Garren has AOM in portfolio , bought at 4.04. He rated it as a buy as recently as 10/29, and sees the ASH meeting in December as a potential catalyst.

To: Ian@SI who wrote (14076)	11/13/2004 12:54:15 PM
From: keokalani'nui	Read Replies (2) \| Respond to of 52153

Ian, I don't know what news feed you've been using, but for some reason News on Yahoo for Anormed comes back with an error; been true for at least a week. In fact, it released 2Q results Wed, which can be found here. cnw.ca A large block traded right after quarterly financial results is probably a pre-arranged sale by a someone with inside information--a board member representing a large shareholder perhaps? That in and of itself was probably enough to take it down 5%. If there was just that one isolated large transaction, I wouldn't worry, at least about the sale itself. Big volume selling into next week, on the other hand..... W